Three therapeutic approaches in tachycardia.
D001281:Atrial Fibrillation / Q000188:drug therapy / Q000628:therapy; D001282:Atrial Flutter / Q000188:drug therapy / Q000628:therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock; D006329:Heart Conduction System; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008026:Ligation; D009388:Neostigmine / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy / Q000628:therapy*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy / Q000628:therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000628:therapy; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy / Q000601:surgery / Q000628:therapy
D004071:Digitalis Glycosides; D009388:Neostigmine; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine